Indira Ravishankar, MD | |
169 Minnisink Rd, Totowa, NJ 07512-1803 | |
(973) 256-1700 | |
(973) 890-4574 |
Full Name | Indira Ravishankar |
---|---|
Gender | Female |
Speciality | General Practice |
Location | 169 Minnisink Rd, Totowa, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1962441873 | NPI | - | NPPES |
834563B1J | Other | NJ | MEDICARE BILLING |
4499701 | Medicaid | NJ |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | MA3665600 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Indira Ravishankar, MD 5 Geiger Ln, Warren, NJ 07059-5639 Ph: (732) 469-0241 | Indira Ravishankar, MD 169 Minnisink Rd, Totowa, NJ 07512-1803 Ph: (973) 256-1700 |
News Archive
The Clinton Health Access Initiative, founded by former President Bill Clinton, with funding from the Bill & Melinda Gates Foundation and the U.K. government, has hired former pharmaceutical company scientists "to tinker with the chemistry used to synthesize a key [HIV] drug, tenofovir" in an effort to reduce "the cost of manufacturing," the Wall Street Journal reports.
Exercise may improve quality of life for people with cancer, according to Cochrane researchers. In two separate Cochrane systematic reviews, the authors gathered together evidence showing that activities such as walking and cycling can benefit those who are undergoing or have completed treatment for cancer.
Technology has made it possible to synthesize increasingly targeted drugs. But scientists still have much to learn from Mother Nature. Pyridomycin, a substance produced by non-pathogenic soil bacteria, has been found to be a potent antibiotic against a related strain of bacteria that cause tuberculosis.
Protagen AG, a specialist for in-vitro diagnostics and GMP-compliant protein analysis announced today a second round of finance totalling a volume of € 10.0 Million.
Research and treatment of head and neck cancers at the University of Colorado Cancer Center reached a new level this month with a highly competitive Specialized Programs of Research Excellence grant from the National Cancer Institute.
› Verified 4 days ago